PARTNERED WITH

Doximity just launched a new free AI tool called Doximity Scribe. It’s designed to help doctors save time by writing notes during patient visits—so we’re not stuck finishing charts in our pajamas.

This isn’t their first AI tool. They’ve already built a free AI assistant and other features into their platform. But Scribe feels like a big step forward. It’s HIPAA-compliant, easy to use, and works across desktop and mobile.

Like any AI scribe, it has its pros and cons. But what really makes this one stand out? It’s free. And it’s already built into a platform used by 80% of U.S. physicians. That’s a pretty strong go-to-market strategy.

In this article, I’ll walk through what Scribe can do, how it fits into Doximity’s larger AI push, and what it could mean for doctors and patient care.

Doximity Scribe is an AI-powered tool that listens during physician-patient conversations and drafts a clinical note in real time. It’s built to make documentation less painful and improve the quality of your notes—without adding extra clicks or software (although, none of it is integrated into the EHR).

You can choose from several note types, including dictation, progress notes, H&Ps, consults, and even meetings. It works across desktop and mobile, and integrates directly with Doximity Dialer if you’re doing virtual visits.

This tool is free for all verified Doximity users—physicians, NPs, PAs, and med students. Right now, Scribe is still in beta, but I’ve tested it out myself—it’s pretty cool.

Doximity already has a bunch of tools my colleagues and I use daily—even before this new AI scribe showed up. Here’s a quick rundown:

Together, these tools make Doximity feel less like a single app and more like an all-in-one operating system for physicians. Scribe is just the latest addition—and it builds on a foundation many of us already rely on.

Do I think 80% of U.S. physicians on Doximity will start using Doximity Scribe overnight? No, probably not.

As I’ve said in past Inefficiency Insights, for a tool to gain real traction with doctors, it needs to either:

When I was working on my first startup to streamline outpatient waitlists, our beta tool worked—but it was a separate platform. Offices loved the concept, but we kept getting the same question: “Does it integrate with our current software?” It didn’t. And that was the dealbreaker. The tool wasn’t so revolutionary that it justified switching tabs or learning something new. Ultimately, that friction killed adoption.

Now back to Scribe—same story, new setting. Doximity Scribe doesn’t integrate with EHRs (at least not yet), and that’s going to be a barrier. Compare that to competitors like Abridge, Nabla, or Sully.ai, which are actively working inside the EHR environment.

But here’s Doximity’s bet: they’re making Scribe free. No strings attached. If it delivers even close to what paid scribes offer—without the $300/month price tag—then maybe, just maybe, physicians will tolerate a little friction.

Plus, Doximity already has our trust. We’re familiar with their tools. That kind of brand equity matters.

Still, the real question is: will it save me enough time to make it worth using?

I’m testing it more in the coming weeks. So far, it’s promising—but I haven’t hit the “I can’t live without this” threshold yet.

In summary, Doximity Scribe is a promising new tool in the growing world of AI scribes. While its lack of EHR integration may slow adoption, its ease of use, mobile access, and zero cost could make it an attractive option—especially for physicians already embedded in Doximity’s ecosystem. Time will tell if it becomes a staple in our documentation workflows.

You can do everything right—diagnose, treat, document—and still wait 45 days (or longer) just to get reimbursed. Sometimes you don’t get paid at all.

The process is so bloated with middlemen, delays, and arbitrary denials that it takes entire departments just to try to get physicians what they’ve already earned. This drains time, money, and morale from the entire system.

But it doesn’t have to be this way. I’ve been thinking a lot about what an alternative could look like…

👉 Full breakdown in my latest Insights article here.

Hospitals don’t handle most of their supply negotiations. That job goes to Group Purchasing Organizations (GPOs)—middlemen that promise savings by pooling hospitals’ buying power. Sounds efficient, right?

What’s interesting is that GPOs aren’t paid by hospitals. They’re paid by the suppliers. In other words, the more money hospitals spend, the more GPOs make. And thanks to a little-known safe harbor in federal law, that setup is perfectly legal.

It’s a model that’s widely accepted—but rarely questioned. And it raises concerns that feel a lot like what we’ve seen with pharmacy benefit managers: vendor-funded entities shaping what gets used in patient care.

So are GPOs actually saving hospitals money—or are they quietly driving up costs behind the scenes?

👉 Read more details here.

We’re halfway through 2025—and it turns out, predicting the future of healthcare is harder than it looks.

At the start of the year, I made 16 calls on where things were headed: the rise of AI agents, the fall of 23andMe, the uncertain fate of GLP-1 compounding, and whether physician-owned hospitals might make a comeback. Some were spot on. Others… not so much.

The pace of change in healthcare, though, is starting to shift—and physicians should be paying close attention to what’s moving fast, what’s stalling, and what’s quietly brewing beneath the surface.

👉 See all my prediction updates here.